Buy Seres Therapeutics Stock | MCRB Stock Price & Latest News | Public
MCRB

Seres Therapeutics

$0.00 (0.00%)Today

    About MCRB

    Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.09
    -0.19
    -0.28
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.26

    Actual EPS
    Q3 2020

    Stats

    Market Cap$2,24B
    Volume28,94k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$33.00
    1 Year Low$2.52
    Open$25.31
    High$25.88
    Low$24.50

    Buy any stock with any amount of money.

    Download the App
    Download the app